BAP1 and neoplasm: Low BAP1 expression was significantly correlated with high serum CA19-9 level (P = 0.001) and aggressive tumor characteristics, such as larger tumor size (P = 0.010), presence of lymphatic metastasis (P < 0.001), and advanced tumor node metastasis (TNM) stage (P = 0.005) (Table 1).